Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Dietary supplement drug therapies for depression.

Howland RH.

J Psychosoc Nurs Ment Health Serv. 2012 Jun;50(6):13-6. doi: 10.3928/02793695-20120508-06. Epub 2012 May 18.

PMID:
22589230
2.

Differentiating prescription omega-3-acid ethyl esters (P-OM3) from dietary-supplement omega-3 fatty acids.

Brunton S, Collins N.

Curr Med Res Opin. 2007 May;23(5):1139-45. Review. Erratum in: Curr Med Res Opin. 2008 Jan;24(1):247.

PMID:
17519081
4.

Patient use of dietary supplements: a clinician's perspective.

Sadovsky R, Collins N, Tighe AP, Brunton SA, Safeer R.

Curr Med Res Opin. 2008 Apr;24(4):1209-16. doi: 10.1185/030079908X280743 . Epub 2008 Mar 17. Review.

PMID:
18348745
5.
6.

Using complementary and alternative medicines for depression.

Fava M.

J Clin Psychiatry. 2010 Sep;71(9):e24. doi: 10.4088/JCP.8157tx3c.

7.

Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. V. Complementary and alternative medicine treatments.

Ravindran AV, Lam RW, Filteau MJ, Lespérance F, Kennedy SH, Parikh SV, Patten SB; Canadian Network for Mood and Anxiety Treatments (CANMAT).

J Affect Disord. 2009 Oct;117 Suppl 1:S54-64. doi: 10.1016/j.jad.2009.06.040. Epub 2009 Aug 8.

PMID:
19666194
8.

Differences between dietary supplement and prescription drug omega-3 fatty acid formulations: a legislative and regulatory perspective.

Collins N, Tighe AP, Brunton SA, Kris-Etherton PM.

J Am Coll Nutr. 2008 Dec;27(6):659-66. Review.

PMID:
19155425
9.

Evidence for S-adenosyl-L-methionine (SAM-e) for the treatment of major depressive disorder.

Papakostas GI.

J Clin Psychiatry. 2009;70 Suppl 5:18-22. doi: 10.4088/JCP.8157su1c.04. Review.

10.

Omega-3 fatty acids in major depressive disorder.

Freeman MP.

J Clin Psychiatry. 2009;70 Suppl 5:7-11. doi: 10.4088/JCP.8157su1c.02. Review.

11.

L-methylfolate (Deplin®): a new medical food therapy as adjunctive treatment for depression.

Roman MW, Bembry FH.

Issues Ment Health Nurs. 2011;32(2):142-3. doi: 10.3109/01612840.2010.541975. No abstract available.

PMID:
21247282
12.

FDA regulation of dietary supplements and requirements regarding adverse event reporting.

Frankos VH, Street DA, O'Neill RK.

Clin Pharmacol Ther. 2010 Feb;87(2):239-44. doi: 10.1038/clpt.2009.263. Epub 2009 Dec 23.

PMID:
20032973
13.

PUFA for human health: diet or supplementation?

Abete P, Testa G, Galizia G, Della-Morte D, Cacciatore F, Rengo F.

Curr Pharm Des. 2009;15(36):4186-90. Review.

PMID:
20041820
14.

Are nutritional supplements ready for prime time?

Mischoulon D, Fava M.

J Clin Psychiatry. 2008 Sep;69(9):1497-8. No abstract available.

PMID:
19193349
15.

Nutrient-based therapies for bipolar disorder: a systematic review.

Sylvia LG, Peters AT, Deckersbach T, Nierenberg AA.

Psychother Psychosom. 2013;82(1):10-9. doi: 10.1159/000341309. Epub 2012 Nov 6. Review.

PMID:
23147067
16.

Dispelling the myths about omega-3 fatty acids.

Sadovsky R, Collins N, Tighe AP, Safeer RS, Morris CM, Brunton SA.

Postgrad Med. 2008 Jul;120(2):92-100. doi: 10.3810/pgm.2008.07.1796. Review.

PMID:
18654074
18.
19.

Efficacy of the dietary supplement S-adenosyl-L-methionine.

Fetrow CW, Avila JR.

Ann Pharmacother. 2001 Nov;35(11):1414-25.

PMID:
11724095
20.

Update and critique of natural remedies as antidepressant treatments.

Mischoulon D.

Obstet Gynecol Clin North Am. 2009 Dec;36(4):789-807, x. doi: 10.1016/j.ogc.2009.10.005.

Items per page

Supplemental Content

Write to the Help Desk